ANDA 74800, held by Actavis Mid Atlantic. Cromolyn Sodium.
As of Nov 21, 2026, ANDA 74800 (Cromolyn Sodium), held by Actavis Mid Atlantic, was first approved by FDA on Jul 26, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 26, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cromolyn Sodium5.2MG/SPRAY · spray, metered;nasal | Cromolyn Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters